The trial posting for RL0003 - A Phase 3b Double-Blind, Ramdomized, Placebo Controlled Study of Rotigotine and its Effect on All-Day Functioning and Quality of Life in Patients with Moderate to Severe Idiopathic Restless Legs Syndrome is not listed as active in clinicaltrials.partners.org database. The trial may have stopped recruiting.